ciprofloxacin has been researched along with Multiple Sclerosis in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multi-resistant nosocomial urinary tract infections occurring in thirty patients with neurogenic bladder dysfunction were treated with ciprofloxacin 100 mg twice daily Early bacteriological eradication was obtained in 48." | 5.06 | Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. ( Baert, L; van Poppel, H, 1987) |
| " The most common adverse events and pharmacodynamic effects are related to plasma concentrations." | 2.44 | A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients. ( Henney, HR; Runyan, JD, 2008) |
| "However the number of septic arthritis cases due to S." | 1.38 | [Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis]. ( Altay, T; Avcı, M; Coşkuner, SA; Havuk, A; Olut, AI; Ozgenç, O; Ozsu Caymaz, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edlich, RF | 1 |
| Olut, AI | 1 |
| Avcı, M | 1 |
| Ozgenç, O | 1 |
| Altay, T | 1 |
| Coşkuner, SA | 1 |
| Ozsu Caymaz, S | 1 |
| Havuk, A | 1 |
| Henney, HR | 1 |
| Runyan, JD | 1 |
| Van Poppel, H | 3 |
| Willemen, P | 1 |
| Wegge, M | 2 |
| Kraseman, P | 1 |
| Chysky, V | 2 |
| Baert, L | 2 |
| Dammekens, H | 1 |
1 review available for ciprofloxacin and Multiple Sclerosis
| Article | Year |
|---|---|
A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
Topics: Chemistry, Pharmaceutical; Ciprofloxacin; Clonidine; Dose-Response Relationship, Drug; Drug Interact | 2008 |
2 trials available for ciprofloxacin and Multiple Sclerosis
| Article | Year |
|---|---|
Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder.
Topics: Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Female; Humans; Male; Microbial Sensiti | 1990 |
Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; M | 1987 |
3 other studies available for ciprofloxacin and Multiple Sclerosis
| Article | Year |
|---|---|
Guardian ad litem, a potentially expensive invitation to either the mismanagement or management of patients with cognitive disorders.
Topics: Aged; Catheters; Ciprofloxacin; Cognition Disorders; Cystostomy; Elder Abuse; Fever; Humans; Legal G | 2010 |
[Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Bursitis; Cip | 2012 |
Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.
Topics: Anti-Infective Agents; Catheters, Indwelling; Ciprofloxacin; Cystitis; Enterobacteriaceae Infections | 1986 |